Dawn Halkuff, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 42,500 shares at $7.28 ($309K) on 2025-08-12, disclosed to the SEC on 2025-08-13.
Open-market sale of $309k XERS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |